|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||
| Current assets | ||||||||||
| Cash | ||||||||||
| Prepaid expenses | ||||||||||
| Total current assets | ||||||||||
| Cash and marketable securities held in Trust Account | ||||||||||
| TOTAL ASSETS | ||||||||||
| LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||
| Liabilities, Current | ||||||||||
| Accrued expenses | ||||||||||
| Income taxes payable | ||||||||||
| Excise tax liability | ||||||||||
| Total current liabilities | ||||||||||
| Convertible promissory note - related party, net of discount | ||||||||||
| Conversion option liability | ||||||||||
| Convertible promissory note—related party, net of discount | ||||||||||
| Extension promissory note—related party | ||||||||||
| Deferred legal fee | ||||||||||
| Warrant liabilities | ||||||||||
| Deferred underwriting fee payable | ||||||||||
| Total liabilities | ||||||||||
| Class A common stock subject to possible redemption, 14,776,252 and 50,000,000 shares at redemption value as of approximately $10.23 and $10.07 as of June 30, 2023 and December 31, 2022, respectively | ||||||||||
| Class A Common Stock | ||||||||||
| Total class A common stock subject to possible redemption, 14,776,252 and 50,000,000 shares at redemption value as of approximately $10.23 and $10.07 as of June 30, 2023 and December 31, 2022, respectively | ||||||||||
| Stockholders' deficit | ||||||||||
| Common stock | ||||||||||
| Class A Common Stock | ||||||||||
| Class B Common Stock | ||||||||||
| Additional paid-in capital | ||||||||||
| Accumulated deficit | ||||||||||
| Total stockholders' deficit | ||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT |
Loading...
